Review Article

Acupuncture Combined with Three-Step Analgesic Drug Therapy for Treatment of Cancer Pain: A Systematic Review and Meta-Analysis of Randomised Clinical Trials

Table 1

Summary of randomised clinical studies of acupuncture combined with three-step analgesic drug therapy for the treatment of cancer pain.

Study (year)Type of cancerSample sizesInterventionsAcupuncture point selectionSession frequency and durationMain outcomes and assessment of pain
TCTC

Wang (2018) [10]Various3535AT + CDrug (three-step analgesic ladder)LI4, LR3, and Ashi point30 min qd 6 weeksResponse rate, NRS, and side effect rate

Wang (2016) [11]Lung cancer3030EA + COxycodone sustained-release tabletsLI4, PC6, ST36, and SP630 min qd 14 daysResponse rate, NRS, side effect rate, burst pain, onset time, and DOR

Zhong (2016) [12]Various3030FA + CMorphine sulfate sustained-release tabletsAshi pointOnce a day 14 daysResponse rate, QOL, and burst pain

Mi (2010) [13]Gastric cancer3230FN + AT + CDrug (three-step analgesic ladder)FN: BL21, BL18, and BL17. AT: CV12, ST25, and St3630 min qod 4 weeksResponse rate and side effect rate

Bai (2019) [14]Various5050FN + CDrug (three-step analgesic ladder)Ashi point, ST36, and SP6qod 14 daysResponse rate, NRS, and side effect rate

Liu (2018) [15]Various7275TEAS + CDrug (three-step analgesic ladder)LI4, PC6, ST36, and SP630 min bid 3 weeksResponse rate, BPI-S, KPS, and side effect rate

Liu (2011) [16]Liver cancer3030AT + CTramadol hydrochloride sustained-release tabletsSP4, PC6, GB41, TE5, SI3, BL62, LU7, KI6, LR3, and LR14qd 14 daysResponse rate, NRS, QOL, side effect rate, onset time, and DOR

Fu (2019) [17]Various16/1616AT + CMorphine hydrochloride sustained-release tabletsPC6 and SP61 h qdResponse rate, NRS, KPS, side effect rate, burst pain, onset time, and DOR
WA + C

Wu (2019) [18]Various3030WA + CDrug (three-step analgesic ladder)Based on syndrome differentiation and disease differentiation12 h qd 10 daysResponse rate, VAS, burst pain, and side effect rate

Dong (2018) [19]Various6060WA + CDrug (three-step analgesic ladder)Based on syndrome differentiation and disease differentiation10–12 h qd 7 daysResponse rate, NRS, QLQ-C30, and side effect rate

Sun (2016) [20]Various3030AT + COxycodoneLI4, PC6, ST36, SP6, Ashi point, and others30 min qd 14 daysResponse rate, NRS, KPS, QOL, and side effect rate

Zhang (2014) [21]Various3030AT + CDrug (three-step analgesic ladder)LI4 and ST36. Lung cancer: PC6 and LU6. Liver cancer: GB34, LR6, and LR3. Colorectal cancer: PC6, CV12, and TE630 min qd 7 daysResponse rate, QOL, side effect rate, onset time, and DOR

Hui (2019) [22]Various4040AT + CDrug (three-step analgesic ladder)Ashi point, LI4, GV14, BL11, GB34, and LR330 min qd 14 daysResponse rate, side effect rate, onset time, and DOR

Tan (2012) [23]Various106101AT + CDrug (three-step analgesic ladder)LI4 and PC6. Lung cancer: LU6. Liver cancer: GB34 and LR6. Colorectal cancer: CV12, ST36, and TE60.5–1 h qd 3 weeksResponse rate and side effect rate

Fan (2017) [24]Lung cancer3534AT + CDrug (three-step analgesic ladder)PC6, LI4, ST36, GB34, and SP620 min qd 20 daysResponse rate, NRS, onset time, and DOR

Jiang (2016) [25]Various2525AT + CDrug (three-step analgesic ladder)Ashi point, LR3, and LI430 min qd 7 daysResponse rate and NRS

Li (2017) [26]Gastric cancer3030AT + CDrug (three-step analgesic ladder)ST36, LR3, and LI430 min qd 7 daysResponse rate, NRS, QOL, and side effect rate

Huang (2018) [27]Various3131AT + CDrug (three-step analgesic ladder)PC6. Lung cancer: LI4, LU4, LU6, and ST36. Liver cancer: GB34 and LR3. Breast cancer: LI4, STI8, and CV9. Gastric cancer: CV12, ST36, and TE630 min qd 7 daysResponse rate

Peng (2012) [28]Various2324EA + CDrug (three-step analgesic ladder)LI4, PC6, ST36, and SP630 min qd 7 daysResponse rate, onset time, and DOR

T: treatment group, C: control group, AT: acupuncture, EA: electroacupuncture, FA: floating acupuncture, FN: fire needle, WA: wrist-ankle acupuncture, DOR: duration of response, NRS: numerical rating scale, BPI-S: brief pain inventory-severity, QOL: quality of life, and KPS: Karnofsky performance status.